Active and Passive Smoking and Risk Factors

A special issue of Medicina (ISSN 1648-9144).

Deadline for manuscript submissions: closed (30 June 2020) | Viewed by 2935

Special Issue Editor


E-Mail Website
Guest Editor
Behavioral and Community Health Sciences, LSUHSC School of Public, New Orleans, LA 70112, USA
Interests: cancer; obesity; sugar-sweetened beverage; behavioral intervention; smoking; health disparities
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Smoking is a major risk factor for many cancer types (e.g., lung, oral, kidney, cervix, liver, bladder, pancreas, stomach, and colon) and other chronic diseases (cardiovascular disease, respiratory illness, hypertension, diabetes, etc.). Although smoking prevalence has significantly declined over the past few decades, especially in developed countries, it is estimated that there are approximately 1.1 billion smokers (20% of the world population) worldwide and six million smoking-attributable deaths per year. In addition to active smoking (including cigarette, e-cigarette, and vape), passive smoking has been shown to impact on health as well. Examples of passive smoking include second-hand smoking (SHS) and third-hand smoking (THS). This passive smoking issue may have a larger impact on vulnerable populations including children, adolescents, and pregnant women than other general populations. Therefore, a better understanding of risk factors associated with active and passive smoking can not only help smokers to quit smoking but can also prevent tobacco-related health problems. In this Special Issue, we solicit articles that investigate/review smoking-related research or identify several major environmental, social behavioral, and genetic risk factors for both active and passive smoking. This issue will provide readers with an overview of updated information regarding potential tobacco control and smoking research.

Dr. Tung-Sung Tseng
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Tobacco control
  • Smoking
  • Risk factors
  • Risky behavior

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

7 pages, 267 KiB  
Brief Report
Targeted Intervention to Reduce Smoking among People with Severe Mental Illness: Implementation of a Smoking Cessation Intervention in an Inpatient Mental Health Setting
by Julia M. Lappin, Dennis Thomas, Jackie Curtis, Stephen Blowfield, Mike Gatsi, Gareth Marr and Ryan Courtney
Medicina 2020, 56(4), 204; https://doi.org/10.3390/medicina56040204 - 24 Apr 2020
Cited by 4 | Viewed by 2645
Abstract
Background and Objectives: Smoking and smoking-related harms are highly prevalent among people with severe mental illness. Targeted smoking cessation programs are much needed in this population. This pilot study aimed to assess the effectiveness of implementing smoking cessation system change interventions within an [...] Read more.
Background and Objectives: Smoking and smoking-related harms are highly prevalent among people with severe mental illness. Targeted smoking cessation programs are much needed in this population. This pilot study aimed to assess the effectiveness of implementing smoking cessation system change interventions within an acute inpatient mental health unit. Materials and Methods: Design: Pre-post intervention study. System change interventions for smoking cessation were delivered over a three-month period (05 March 2018–04 June 2018) on an acute inpatient mental health unit. Participants (n = 214) were all individuals receiving care as inpatients during the three-month intervention. Outcomes assessed pre- and post-intervention were: (i) recording of patient smoking status in medical notes, (ii) number of inpatients offered smoking cessation medication, and iii) number of violent incidents reported. Results: Recording of smoking status significantly increased from 1.9% to 11.4% (X2 = 14.80; p ≤ 0.001). The proportion of inpatients offered smoking cessation treatment significantly increased from 11.0% to 26.8% (X2 = 16.01; p ≤ 0.001). The number of violent incidents decreased by half, which was not statistically significant. Conclusion: Evidence-based smoking cessation interventions can be successfully implemented on an inpatient mental health unit. Modest gains were made in routine screening for smoking and in smoking cessation treatment prescription. Future studies should prioritize effective participatory collaboration with staff to optimize effectiveness of interventions and should include additional strategies such as brief intervention training and smoking cessation treatments such as varenicline and buproprion in addition to nicotine replacement therapy (NRT). Full article
(This article belongs to the Special Issue Active and Passive Smoking and Risk Factors)
Back to TopTop